Murphy PB - Search Results

1

A phase I study of panobinostat in combination with gemcitabine in the treatment of solid tumors.

Jones SF, Bendell JC, Infante JR, Spigel DR, Thompson DS, Yardley DA, Greco FA, Murphy PB, Burris HA 3rd. Jones SF, et al. Among authors: murphy pb. Clin Adv Hematol Oncol. 2011 Mar;9(3):225-30. Clin Adv Hematol Oncol. 2011. PMID: 21475129 Clinical Trial.

2

A phase II trial of vinflunine as monotherapy or in combination with trastuzumab as first-line treatment of metastatic breast cancer.

Yardley DA, McCleod M, Schreiber F, Murphy P, Patton J, Thompson DS, Shastry M, Rubin M, Melnik M, Burris HA, Hainsworth JD. Yardley DA, et al. Cancer Invest. 2010 Nov;28(9):925-31. doi: 10.3109/07357907.2010.496755. Cancer Invest. 2010. PMID: 20690806 Clinical Trial.

3

A Phase I Study of the Hsp90 Inhibitor AUY922 plus Capecitabine for the Treatment of Patients with Advanced Solid Tumors.

Bendell JC, Jones SF, Hart L, Pant S, Moyhuddin A, Lane CM, Earwood C, Murphy P, Patton J, Penley WC, Thompson D, Infante JR. Bendell JC, et al. Cancer Invest. 2015;33(10):477-82. doi: 10.3109/07357907.2015.1069834. Epub 2015 Oct 13. Cancer Invest. 2015. PMID: 26460795 Clinical Trial.

4

Paclitaxel/carboplatin plus bevacizumab/erlotinib in the first-line treatment of patients with carcinoma of unknown primary site.

Hainsworth JD, Spigel DR, Thompson DS, Murphy PB, Lane CM, Waterhouse DM, Naot Y, Greco FA. Hainsworth JD, et al. Among authors: murphy pb. Oncologist. 2009 Dec;14(12):1189-97. doi: 10.1634/theoncologist.2009-0112. Epub 2009 Dec 4. Oncologist. 2009. PMID: 19965914 Free article. Clinical Trial.

5

Phase II trial of irinotecan, carboplatin, and bevacizumab in the treatment of patients with extensive-stage small-cell lung cancer.

Spigel DR, Greco FA, Zubkus JD, Murphy PB, Saez RA, Farley C, Yardley DA, Burris HA 3rd, Hainsworth JD. Spigel DR, et al. Among authors: murphy pb. J Thorac Oncol. 2009 Dec;4(12):1555-60. doi: 10.1097/JTO.0b013e3181bbc540. J Thorac Oncol. 2009. PMID: 19875975 Free article. Clinical Trial.

6

TAK-228 (formerly MLN0128), an investigational dual TORC1/2 inhibitor plus paclitaxel, with/without trastuzumab, in patients with advanced solid malignancies.

Burris HA 3rd, Kurkjian CD, Hart L, Pant S, Murphy PB, Jones SF, Neuwirth R, Patel CG, Zohren F, Infante JR. Burris HA 3rd, et al. Among authors: murphy pb. Cancer Chemother Pharmacol. 2017 Aug;80(2):261-273. doi: 10.1007/s00280-017-3343-4. Epub 2017 Jun 10. Cancer Chemother Pharmacol. 2017. PMID: 28601972 Clinical Trial.

7

Addition of bevacizumab to three docetaxel regimens as adjuvant therapy for early stage breast cancer.

Yardley DA, Hart L, Waterhouse D, Whorf R, Drosick DR, Murphy P, Badarinath S, Daniel BR, Childs BH, Burris H. Yardley DA, et al. Breast Cancer Res Treat. 2013 Dec;142(3):655-65. doi: 10.1007/s10549-013-2764-y. Epub 2013 Nov 21. Breast Cancer Res Treat. 2013. PMID: 24253810 Clinical Trial.

8

Sorafenib Plus Ixabepilone as First-Line Treatment of Metastatic HER2-Negative Breast Cancer: A Sarah Cannon Research Institute Phase I/II Trial.

Yardley DA, Dickson N, Drosick D, Earwood C, Inhorn R, Murphy P, Hainsworth JD. Yardley DA, et al. Clin Breast Cancer. 2016 Jun;16(3):180-7. doi: 10.1016/j.clbc.2016.02.003. Epub 2016 Feb 12. Clin Breast Cancer. 2016. PMID: 26943991 Clinical Trial.

9

A Phase II Study with Lead-In Safety Cohort of 5-Fluorouracil, Oxaliplatin, and Lapatinib in Combination with Radiation Therapy as Neoadjuvant Treatment for Patients with Localized HER2-Positive Esophagogastric Adenocarcinomas.

Shepard G, Arrowsmith ER, Murphy P, Barton JH Jr, Peyton JD, Mainwaring M, Blakely L, Maun NA, Bendell JC. Shepard G, et al. Oncologist. 2017 Oct;22(10):1152-e98. doi: 10.1634/theoncologist.2017-0186. Epub 2017 Aug 1. Oncologist. 2017. PMID: 28765502 Free PMC article. Clinical Trial.

10

Use of a multiplexed immunoassay (PRO Onc assay) to detect HER2 abnormalities in circulating tumor cells of women with HER2-negative metastatic breast cancer: lack of response to HER2-targeted therapy.

Hainsworth JD, Murphy PB, Alemar JR, Daniel BR, Young RR, Yardley DA. Hainsworth JD, et al. Among authors: murphy pb. Breast Cancer Res Treat. 2016 Nov;160(1):41-49. doi: 10.1007/s10549-016-3969-7. Epub 2016 Sep 8. Breast Cancer Res Treat. 2016. PMID: 27632289

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

176 results

Search Page

Filters